Consolidated Statement Of Income

Chiome Bioscience Inc. - Filing #7727647

Concept	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2017-01-01 to 2017-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31	2016-01-01 to 2016-12-31
Consolidated statement of income
Statement of income
Net sales	—	—	259,895,000 JPY	—	59,561,000 JPY	259,895,000 JPY	JPY	200,334,000 JPY	224,800,000 JPY	—	—	252,215,000 JPY	252,215,000 JPY	JPY	—	27,414,000 JPY
Cost of sales	—	—	—	—	—	85,481,000 JPY	—	—	—	—	—	137,798,000 JPY	—	—	—	—
Operating expenses
Selling, general and administrative expenses	—	—	—	—	—	1,062,282,000 JPY	—	—	—	—	—	1,156,774,000 JPY	—	—	—	—
Other	—	—	—	—	—	469,898,000 JPY	—	—	—	—	—	530,075,000 JPY	—	—	—	—
Operating expenses
Gross profit (loss)	—	—	—	—	—	174,414,000 JPY	—	—	—	—	—	114,417,000 JPY	—	—	—	—
Net sales
Operating profit (loss)	—	—	174,414,000 JPY	—	57,006,000 JPY	-887,868,000 JPY	-1,062,282,000 JPY	117,407,000 JPY	94,232,000 JPY	—	—	-1,042,357,000 JPY	114,417,000 JPY	-1,156,774,000 JPY	—	20,184,000 JPY
Ordinary profit (loss)	—	—	—	—	—	-883,627,000 JPY	—	—	—	—	—	-1,047,157,000 JPY	—	—	—	—
Operating expenses
Research and development expenses	—	—	—	—	—	592,384,000 JPY	—	—	—	—	—	626,699,000 JPY	—	—	—	—
Non-operating income
Interest income	—	—	—	—	—	41,000 JPY	—	—	—	—	—	150,000 JPY	—	—	—	—
Interest on securities	—	—	—	—	—	JPY	—	—	—	—	—	2,156,000 JPY	—	—	—	—
Other	—	—	—	—	—	627,000 JPY	—	—	—	—	—	805,000 JPY	—	—	—	—
Non-operating income	—	—	—	—	—	6,663,000 JPY	—	—	—	—	—	7,645,000 JPY	—	—	—	—
Extraordinary income	—	—	—	—	—	5,232,000 JPY	—	—	—	—	—	6,228,000 JPY	—	—	—	—
Selling, general and administrative expenses
Cost of sales
Non-operating expenses	—	—	—	—	—	2,423,000 JPY	—	—	—	—	—	12,445,000 JPY	—	—	—	—
Interest expenses	—	—	—	—	—	185,000 JPY	—	—	—	—	—	483,000 JPY	—	—	—	—
Share issuance costs	—	—	—	—	—	1,894,000 JPY	—	—	—	—	—	4,949,000 JPY	—	—	—	—
Extraordinary losses	—	—	—	—	—	1,755,000 JPY	—	—	—	—	—	460,351,000 JPY	—	—	—	—
Impairment losses	—	—	JPY	—	JPY	JPY	JPY	JPY	JPY	—	—	321,466,000 JPY	JPY	321,466,000 JPY	—	JPY
Other	—	—	—	—	—	JPY	—	—	—	—	—	84,000 JPY	—	—	—	—
Non-operating expenses
Other	—	—	—	—	—	343,000 JPY	—	—	—	—	—	115,000 JPY	—	—	—	—
Gross profit
Profit (loss) before income taxes	—	—	—	—	—	-880,150,000 JPY	—	—	—	—	—	-1,501,280,000 JPY	—	—	—	—
Extraordinary income
Gain on sale of non-current assets	—	—	—	—	—	2,050,000 JPY	—	—	—	—	—	JPY	—	—	—	—
Income taxes - current	—	—	—	—	—	2,420,000 JPY	—	—	—	—	—	2,420,000 JPY	—	—	—	—
Income taxes - deferred	—	—	—	—	—	JPY	—	—	—	—	—	-12,537,000 JPY	—	—	—	—
Extraordinary losses
Loss on sale of non-current assets	—	—	—	—	—	1,755,000 JPY	—	—	—	—	—	JPY	—	—	—	—
Income taxes	—	—	—	—	—	2,420,000 JPY	—	—	—	—	—	-10,117,000 JPY	—	—	—	—
Profit (loss)	-882,570,000 JPY	-882,570,000 JPY	—	-882,570,000 JPY	—	-882,570,000 JPY	—	—	—	-1,491,162,000 JPY	-1,491,162,000 JPY	-1,491,162,000 JPY	—	—	-1,491,162,000 JPY	—